TruBridge Delays Reporting to Complete Year-End Audit, Sets New Earnings Release and Call Schedule TruBridge, Inc. has announced a revised schedule for the release of its financial results for the…
Emmaus Life Sciences Announces Full-Year 2025 Financial Results Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company focused on treatments for sickle cell disease, has reported its financial condition and operating…
Merck Reports Positive Phase 2 CADENCE Results for WINREVAIR in CpcPH-HFpEF, Supporting Advancement to Phase 3 Merck has announced encouraging results from its Phase 2 CADENCE clinical trial evaluating WINREVAIR™…
Incyte Reports Positive 54-Week Povorcitinib Results in Hidradenitis Suppurativa at AAD 2026 Incyte has reported encouraging long-term results from its Phase 3 STOP-HS clinical trial program, highlighting the sustained efficacy…
SBC Medical Reports Strong Q4 Profit Growth Despite Full-Year Revenue Decline in 2025 SBC Medical Group Holdings Incorporated a management services organization supporting a wide network of franchise-based medical businesses,…
Recognized for Driving Digital Transformation and Advancing a More Resilient, Data-Driven Healthcare Supply Chain Universal Health Services, Inc. (UHS), headquartered in King of Prussia, Pennsylvania, continues to solidify its reputation…
Multiple Ivonescimab Data Sets from Phase III Studies to Be Highlighted at ELCC 2026 Summit Therapeutics Inc. has announced the presentation of multiple updated datasets for its investigational bispecific antibody,…
Alpha Cognition Reports Strong Fiscal 2025 Results, Highlights Growing Momentum for ZUNVEYL and Strategic Progress Toward Profitability Alpha Cognition ,a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases,…
Pediatrix Partners with Tennessee Maternal-Fetal Medicine to Expand Maternal Care Services Pediatrix Medical Group, Inc., a prominent provider of physician services across the United States, has announced a strategic expansion…
Agenus to Host March 2026 Webcast on Advancing BOT+BAL Immunotherapy and Expanding Patient Access Agenus , a biotechnology company at the forefront of immuno-oncology innovation, has announced that it will…
Banyan Treatment Centers and HoloMD Reveal Promising 90-Day Pilot Results for AI-Driven Post-Discharge Recovery Care In a significant step forward for post-discharge recovery care, Banyan Treatment Centers, a national leader…
Centurion Foundation Secures Future of Two Rhode Island Safety-Net Hospitals Through Non-Profit Transition In a major development for healthcare access in Rhode Island, the Centurion Foundation has successfully stabilized two…